Effects of Somatostatin on Oddi Sphincter Motility and Exocrine Function after Pancreatic Transplantation with Bladder Drainage in Dogs

李桂臣,原春辉,程颖,刘永锋

DOI: https://doi.org/10.3760/cma.j.issn.1007-8118.2005.01.010

2005-01-01

Abstract:Objective To study the effects of somatostatin on Oddi sphincter (SO) motility and graft exocrine function after pancreatic transplantation with bladder drainage in dogs. Methods SO manometry was performed in normal dogs and those receiving pancreatic transplantation with bladder drainage before and after administration of somatostatin. Meanwhile, the urine levels of TAP and amylase before and after administration of somatostatin were determined postoperatively. Results In the control dogs, SO basal pressure, the frequency, amplitude and motility index were significantly decreased from 18.5±2.8 mmHg, (9.7±1.5) per min, 47.1±5.5 mmHg and 235.6±56.1 before to 11.5±4.3 mmHg, (3.8±0.8) per min, 22.7±5.3 mmHg and 76.9±16.4 in 1-2 min after administration of somatostatin. In the dogs receiving pancreatic transplantation, the basal pressure and the frequency were markedly increased to 27.8±2.8 mmHg and (13.1±1.9) per min as compared with the controls (P0.01). After the administration of somatostatin, the basal pressure and motility index were remarkably increased to 35.2 mmHg and 418.7±81.5 in the dogs receiving the pancreatic transplantation (P0.01). However, there were no significant changes in the frequency and amplitude. Urine levels of amylase and active trypsin were significantly decreased on day 5 after the administration of somatostatin (P0.01). Conclusions Somatostatin can inhibit SO motility in the control dogs but simulate it after transplantation. Meanwhile, it can decrease urine levels of amylase and trypsinogen activation peptide. This will help to prevent graft pancreatitis.